Literature DB >> 6114686

Automated gas chromatography for studies of midazolam pharmacokinetics.

D J Greenblatt, A Locniskar, H R Ochs, P M Lauven.   

Abstract

Plasma midazolam concentrations following single therapeutic doses can be quantitated using electron-capture gas-liquid chromatography. After addition of a benzodiazepine analogue as an internal standard, samples are extracted with benzeneisoamyl alcohol (98.5:1.5). The organic extract is evaporated to dryness, reconstituted, and chromatographed on an SP-2250 liquid phase. The automatic sampler allows up to 100 chromatographic analyses per 24-h period. The sensitivity limits are 2-3 ng of midazolam per ml of plasma, and the variation of identical samples is 7 per cent or less. The method was used in a study of six females who received single intravenous doses of midazolam for purposes of anesthetic induction prior to minor gynecologic procedures. Mean (+/- SE) kinetic variables for midazolam were: volume of central compartment, 0.37 (+/ 0.06 l/kg; total volume of distribution, 1.72 (+/- 0.05) l/kg: initial distribution half-life, 7.2 (+/- 1.6) min; elimination half-life, 2.5 (+/- 0.2) h; total clearance, 8.1 (+/- 0.52) ml.min-1.kg-1.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6114686     DOI: 10.1097/00000542-198108000-00014

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  24 in total

1.  An approximate model-independent method to maintain constant plasma levels of intravenous drugs.

Authors:  J M Bailey
Journal:  J Pharmacokinet Biopharm       Date:  1991-12

Review 2.  Clinical pharmacokinetics of non-opiate abused drugs.

Authors:  U Busto; R Bendayan; E M Sellers
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

3.  Midazolam-sufentanil anaesthesia for phaeochromocytoma resection.

Authors:  J D Shapiro; A el-Ganzouri; P F White; A D Ivankovich
Journal:  Can J Anaesth       Date:  1988-03       Impact factor: 5.063

4.  [Analytic data of the new benzodiazepine derivative midazolam (Dormicum) and its metabolites].

Authors:  H Schütz
Journal:  Z Rechtsmed       Date:  1985

Review 5.  Intravenous anaesthetic agents. Pharmacokinetic-pharmacodynamic relationships.

Authors:  B N Swerdlow; F O Holley
Journal:  Clin Pharmacokinet       Date:  1987-02       Impact factor: 6.447

6.  Ambulatory motor activity monitoring to study the timecourse of hypnotic action.

Authors:  A A Borbély
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

7.  Pharmacokinetics and bioavailability of midazolam in man.

Authors:  P Heizmann; M Eckert; W H Ziegler
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

8.  Extra-hepatic metabolism of midazolam.

Authors:  G R Park; A R Manara; S Dawling
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

9.  Midazolam infusion for basal sedation in intensive care: absence of accumulation.

Authors:  S Michalk; C Moncorge; A Fichelle; O Huot; F Servin; R Farinotti; J M Desmonts
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

10.  Assay of midazolam and brotizolam in plasma by a gas chromatographic and a radioreceptor technique.

Authors:  R Jochemsen; P A Van Rijn; T G Hazelzet; D D Breimer
Journal:  Pharm Weekbl Sci       Date:  1983-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.